450 related articles for article (PubMed ID: 16620187)
1. Microbicide preference among young women in California.
Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
[TBL] [Abstract][Full Text] [Related]
2. Women's interest in vaginal microbicides.
Darroch JE; Frost JJ
Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
[TBL] [Abstract][Full Text] [Related]
3. Preparing for microbicide trials in Rwanda: focus group discussions with Rwandan women and men.
Veldhuijzen N; Nyinawabega J; Umulisa M; Kankindi B; Geubbels E; Basinga P; Vyankandondera J; Van De Wijgert J
Cult Health Sex; 2006; 8(5):395-406. PubMed ID: 16923644
[TBL] [Abstract][Full Text] [Related]
4. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women.
Olsen ML; Cwiak CA; Koudelka C; Jensen JT
Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444
[TBL] [Abstract][Full Text] [Related]
5. Challenges to microbicide introduction in South Africa.
Orner P; Harries J; Cooper D; Moodley J; Hoffman M; Becker J; McGrory E; Dabash R; Bracken H
Soc Sci Med; 2006 Aug; 63(4):968-78. PubMed ID: 16600447
[TBL] [Abstract][Full Text] [Related]
6. Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection.
Hoel N; Shaikh S; Kagee A
Ethn Health; 2011 Apr; 16(2):89-106. PubMed ID: 21328113
[TBL] [Abstract][Full Text] [Related]
7. [Acceptability of vaginal microbicides among female sex workers in urban Beijing, China].
Han L; Lv F; Zhang GL; Wu ZL
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):136-8. PubMed ID: 19565872
[TBL] [Abstract][Full Text] [Related]
8. Microbicide applicators: understanding design preferences among women in the dominican republic and South Africa.
Cohen JA; Steele MS; Ureña FI; Beksinska ME
Sex Transm Dis; 2007 Jan; 34(1):15-9. PubMed ID: 16691157
[TBL] [Abstract][Full Text] [Related]
9. Promoting continuous use as a strategy for achieving adherence in a trial of the diaphragm with candidate microbicide.
Penman-Aguilar A; Swezey T; Turner AN; Bell AJ; Ramiandrisoa FN; Legardy-Williams J; Randrianasolo B; Van Damme K; Dulyx J; Behets F; Jamieson DJ
AIDS Educ Prev; 2009 Dec; 21(6):512-25. PubMed ID: 20030496
[TBL] [Abstract][Full Text] [Related]
10. Patterns of sexual behaviour and reported symptoms of STI/RTIs among young people in Croatia--implications for interventions' planning.
Bozicević I; Stulhofer A; Ajduković D; Kufrin K
Coll Antropol; 2006 Dec; 30 Suppl 2():63-70. PubMed ID: 17508477
[TBL] [Abstract][Full Text] [Related]
11. Educating men about vaginal microbicides: considerations from Kenya.
Gitome SW; Kwena ZA; Harper CC; Cohen CR; Bukusi EA
Cult Health Sex; 2020 Jun; 22(6):660-674. PubMed ID: 31241426
[TBL] [Abstract][Full Text] [Related]
12. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials.
van de Wijgert JH; Kilmarx PH; Jones HE; Karon JM; Chaikummao S
Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677
[TBL] [Abstract][Full Text] [Related]
13. Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.
Montandon M; Sahin-Hodoglugil NN; Bukusi E; Agot K; Boland B; Cohen CR
Sex Health; 2008 Dec; 5(4):339-46. PubMed ID: 19061553
[TBL] [Abstract][Full Text] [Related]
14. Vaginal microbicide preferences among midwestern urban adolescent women.
Tanner AE; Katzenstein JM; Zimet GD; Cox DS; Cox AD; Fortenberry JD
J Adolesc Health; 2008 Oct; 43(4):349-56. PubMed ID: 18809132
[TBL] [Abstract][Full Text] [Related]
15. Microbicide acceptability research: current approaches and future directions.
Mantell JE; Myer L; Carballo-Diéguez A; Stein Z; Ramjee G; Morar NS; Harrison PF
Soc Sci Med; 2005 Jan; 60(2):319-30. PubMed ID: 15522488
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.
Nel AM; Mitchnick LB; Risha P; Muungo LT; Norick PM
J Womens Health (Larchmt); 2011 Aug; 20(8):1207-14. PubMed ID: 21774672
[TBL] [Abstract][Full Text] [Related]
17. Adolescents' descriptions of the physical characteristics of microbicide surrogates and experiences of use.
Zubowicz EA; Oakes JK; Short MB; Perfect MM; Succop PS; Rosenthal SL
J Womens Health (Larchmt); 2006 Oct; 15(8):952-61. PubMed ID: 17087619
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
[TBL] [Abstract][Full Text] [Related]
19. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
[TBL] [Abstract][Full Text] [Related]
20. Many vaginal microbicide trial participants acknowledged they had misreported sensitive sexual behavior in face-to-face interviews.
Turner AN; De Kock AE; Meehan-Ritter A; Blanchard K; Sebola MH; Hoosen AA; Coetzee N; Ellertson C
J Clin Epidemiol; 2009 Jul; 62(7):759-65. PubMed ID: 19013762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
